🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
120 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 80.0mg (136 products)
Median 80.0mg This product: 80mg

Other Ingredients

Mannitol Sorbitol natural Chocolate flavor Hydroxypropyl Methylcellulose natural Peppermint flavor Colloidal Silicon Dioxide Stearic Acid Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (79% of products) Nutrient (2% of products) No Claim (1% of products)

Target Groups

Women (not pregnant or lactating) Adult Female (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: 1 to 2 tablets twice daily. Place tablet under the tongue and allow to dissolve slowly, altering the position of the tablet to avoid prolonged contact with the same area. For best results, use this product for at least 4 weeks.

⚠️ Warnings & Precautions

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

🧪 Formulation Notes

Black cohosh sublingual

May help reduce hot flashes

During pre-menopause, excess luteinizing hormone is released from the pituitary gland in a futile attempt to raise estrogen levels. Source Naturals Cimi-Fem black cohosh sublingual tablets contain phytoestrogens and other compounds which may help reduce the frequency of hot flashes.

The sublingual form is absorbed directly into the bloodstream, via the blood vessels under the tongue and into cheeks, bypassing digestion and allowing for quick entry into the system.

Product Details

UPC / SKU 0 21078 01069 2
DSLD Entry Date 2023-06-22
Product Type Botanical
Form Tablet or Pill
DSLD ID 295648
Data Updated 2026-04-11

Research Evidence

31 Research Sources
49 Avg Quality Score
23 Systematic Review
5 Meta Analysis
1 Rct
1 Openfda Safety
B [Efficacy of black cohosh extracts for improving low estrogen status induced by postoperative GnRHa treatment in patients with endometriosis: a systematic review]
Systematic Review Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020
B Black cohosh (Cimicifuga spp.) for menopausal symptoms
Meta Analysis The Cochrane database of systematic reviews 2012
B Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Systematic Review BJOG : an international journal of obstetrics and gynaecology 2017
C Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract
Meta Analysis Menopause (New York, N.Y.) 2011
C Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
Meta Analysis Climacteric : the journal of the International Menopause Society 2021
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2007
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2011
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2010
C Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Meta Analysis Menopause (New York, N.Y.) 2023
C Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Meta Analysis Alternative therapies in health and medicine 2010
View all evidence for Black Cohosh →

Compare Similar Products

View all Black Cohosh products →